TheJobsMapArovella Therapeutics ASX: ALA jobs and careers
About Arovella Therapeutics ASX: ALA
Biotechnology, cell therapy, oncology, iNKT cell therapy, invariant natural killer T (iNKT) cell therapy platform, blood cancers, solid tumours, gastric & pancreatic cancers.
- Founded
- 1999
- Employees
- 11 to 50
Leadership
The top of Arovella Therapeutics ASX: ALA's org chart, with how many people report into each leader.
MB
Michael Baker
CEO & Managing Director
6 reports
NW
Nicole van der Weerden
Chief Operating Officer
5 reports
Jobs at Arovella Therapeutics ASX: ALA
No open positions right now. Explore more companies on TheJobsMap.